Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | JNJ-64457107 |
| Trade Name | |
| Synonyms | ADC-1013|Mitazalimab|JNJ 7107 |
| Drug Descriptions |
JNJ-64457107 (mitazalimab) is a CD40 agonist that may lead to a T-cell dependent antitumor response, potentially resulting in tumor growth inhibition (PMID: 25316820, PMID: 30664811). |
| DrugClasses | CD40 Antibody 16 |
| CAS Registry Number | 2055640-86-1 |
| NCIT ID | C121538 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Fluorouracil + Irinotecan + JNJ-64457107 + Leucovorin + Oxaliplatin | Fluorouracil Irinotecan JNJ-64457107 Leucovorin Oxaliplatin | 0 | 1 |
| JNJ-64457107 | JNJ-64457107 | 0 | 2 |